NEW YORK, Aug. 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Five Prime Therapeutics, Inc. FPRX, Akorn, Inc. AKRX, The Blackstone Group L.P. BX, Avaya Holdings Corp. AVYA, Tractor Supply Company TSCO, and CymaBay Therapeutics Inc. CBAY, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
FPRX DOWNLOAD: http://Fundamental-Markets.com/register/?so=FPRX
AKRX DOWNLOAD: http://Fundamental-Markets.com/register/?so=AKRX
BX DOWNLOAD: http://Fundamental-Markets.com/register/?so=BX
AVYA DOWNLOAD: http://Fundamental-Markets.com/register/?so=AVYA
TSCO DOWNLOAD: http://Fundamental-Markets.com/register/?so=TSCO
CBAY DOWNLOAD: http://Fundamental-Markets.com/register/?so=CBAY
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Five Prime Therapeutics, Inc. FPRX, Akorn, Inc. AKRX, The Blackstone Group L.P. BX, Avaya Holdings Corp. AVYA, Tractor Supply Company TSCO, and CymaBay Therapeutics Inc. CBAY on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed July 30th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
FIVE PRIME THERAPEUTICS, INC. (FPRX) REPORT OVERVIEW
Five Prime Therapeutics' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Five Prime Therapeutics reported revenue of $32.49MM vs $10.14MM (up 220.53%) and basic earnings per share -$0.63 vs -$1.21. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Five Prime Therapeutics reported revenue of $39.51MM vs $30.69MM (up 28.73%) and basic earnings per share -$5.38 vs -$2.44. Five Prime Therapeutics is expected to report earnings on August 8th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$1.58. The estimated EPS forecast for the next fiscal year is -$4.74 and is expected to report on February 26th, 2019.
To read the full Five Prime Therapeutics, Inc. (FPRX) report, download it here: http://Fundamental-Markets.com/register/?so=FPRX
-----------------------------------------
AKORN, INC. (AKRX) REPORT OVERVIEW
Akorn's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Akorn reported revenue of $184.06MM vs $253.42MM (down 27.37%) and basic earnings per share -$0.23 vs $0.33. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Akorn reported revenue of $841.05MM vs $1,116.84MM (down 24.69%) and basic earnings per share -$0.20 vs $1.50.
To read the full Akorn, Inc. (AKRX) report, download it here: http://Fundamental-Markets.com/register/?so=AKRX
-----------------------------------------
THE BLACKSTONE GROUP L.P. (BX) REPORT OVERVIEW
The Blackstone Group's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, The Blackstone Group reported revenue of $1,769.13MM vs $1,914.72MM (down 7.60%) and basic earnings per share $0.55 vs $0.68 (down 19.12%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, The Blackstone Group reported revenue of $7,119.05MM vs $5,125.83MM (up 38.89%) and basic earnings per share $2.21 vs $1.60 (up 38.13%). The Blackstone Group is expected to report earnings on October 18th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.69. The estimated EPS forecast for the next fiscal year is $3.14 and is expected to report on February 7th, 2019.
To read the full The Blackstone Group L.P. (BX) report, download it here: http://Fundamental-Markets.com/register/?so=BX
-----------------------------------------
AVAYA HOLDINGS CORP. (AVYA) REPORT OVERVIEW
Avaya's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Avaya reported revenue of $672.00MM vs $804.00MM (down 16.42%) and basic earnings per share -$1.18 vs -$0.03. For the twelve months ended September 30th, 2017 vs September 30th, 2016, Avaya reported revenue of $3,272.00MM vs $3,702.00MM (down 11.62%) and basic earnings per share -$0.43 vs -$1.54. Avaya is expected to report earnings on August 9th, 2018. The report will be for the fiscal period ending June 30th, 2018.
To read the full Avaya Holdings Corp. (AVYA) report, download it here: http://Fundamental-Markets.com/register/?so=AVYA
-----------------------------------------
TRACTOR SUPPLY COMPANY (TSCO) REPORT OVERVIEW
Tractor Supply's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Tractor Supply reported revenue of $1,682.90MM vs $1,564.08MM (up 7.60%) and basic earnings per share $0.57 vs $0.46 (up 23.91%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Tractor Supply reported revenue of $7,256.38MM vs $6,779.58MM (up 7.03%) and basic earnings per share $3.31 vs $3.29 (up 0.61%). Tractor Supply is expected to report earnings on October 24th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.72. The estimated EPS forecast for the next fiscal year is $4.56 and is expected to report on January 30th, 2019.
To read the full Tractor Supply Company (TSCO) report, download it here: http://Fundamental-Markets.com/register/?so=TSCO
-----------------------------------------
CYMABAY THERAPEUTICS INC. (CBAY) REPORT OVERVIEW
CymaBay Therapeutics' Recent Financial Performance
CymaBay Therapeutics is expected to report earnings on August 9th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.31. The estimated EPS forecast for the next fiscal year is -$1.14 and is expected to report on March 21st, 2019.
To read the full CymaBay Therapeutics Inc. (CBAY) report, download it here: http://Fundamental-Markets.com/register/?so=CBAY
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
